Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

120.3K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
120.3K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.0K
6.0K
Amyloid Fibrils03:03

Amyloid Fibrils

11.0K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

532
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
532

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Innovative vaccine strategies for enhanced flavivirus immunization.

Frontiers in cellular and infection microbiology·2025
Same author

Osteogenic Differentiation of Mesenchymal Stem Cells Induced by Geometric Mechanotransductive 3D-Printed Poly-(L)-Lactic Acid Matrices.

International journal of molecular sciences·2025
Same author

Boosting immunity: synergistic antiviral effects of luteolin, vitamin C, magnesium and zinc against SARS-CoV-2 3CLpro.

Bioscience reports·2024
Same author

3-chymotrypsin-like protease in SARS-CoV-2.

Bioscience reports·2024
Same author

Residues in the fructose-binding pocket are required for ketohexokinase-A activity.

The Journal of biological chemistry·2024
Same author

Neural Tracing Protein-Functionalized Nanoparticles Capable of Fast Retrograde Axonal Transport in Live Neurons.

Small (Weinheim an der Bergstrasse, Germany)·2024

Related Experiment Video

Updated: Nov 9, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.8K

Destination Amyotrophic Lateral Sclerosis.

Matt Keon1, Benjamin Musrie1, Marcel Dinger2

  • 1GenieUs Genomics Pty Ltd., Sydney, NSW, Australia.

Frontiers in Neurology
|April 15, 2021
PubMed
Summary

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease. This review explores how diverse factors converge to define ALS progression, offering insights for future treatments.

Keywords:
early signsgene-environment interactionmotor neuronsneurodegenerationneuromuscular diseasepathophysiology

More Related Videos

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.3K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.8K

Related Experiment Videos

Last Updated: Nov 9, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

9.8K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.3K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.8K

Area of Science:

  • Neuroscience
  • Neurology
  • Genetics

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting motor neurons.
  • The progression of ALS is complex, involving multiple, evolving factors.
  • Understanding the convergence of these factors is crucial but poorly understood.

Purpose of the Study:

  • To review hypotheses and mechanisms of ALS progression.
  • To provide a framework for understanding how diverse factors functionally connect in ALS.
  • To guide future research and therapeutic strategies for ALS and other neurodegenerative diseases.

Main Methods:

  • Literature review of existing hypotheses and proposed mechanisms.
  • Analysis of the functional convergence of different entities in ALS progression.
  • Philosophical exploration of early disease indicators and their link to neurodegeneration.

Main Results:

  • Early symptomatic leads in ALS are consistently linked to cellular, molecular, and genomic neurodegeneration.
  • A hierarchical explanatory framework for ALS progression is proposed.
  • The review consolidates diverse ideas into a common functional reference frame.

Conclusions:

  • Understanding the early stages and underlying neurodegeneration is key to comprehending ALS endpoints.
  • A unified framework can enhance the understanding of ALS.
  • Consolidated insights can be applied to other neurodegenerative diseases.